Target
Egl nine homolog 1 [179-426]
Ligand
BDBM102336
Substrate
n/a
Meas. Tech.
Activity Assay
pH
7.5±n/a
Temperature
298.15±n/a K
IC50
11000±n/a nM
Comments
extracted
Citation
 Shalwitz, RGardner, JH Methods for increasing the stabilization of hypoxia inducible factor-α US Patent  US9278930 Publication Date 3/8/2016 
Target
Name:
Egl nine homolog 1 [179-426]
Synonyms:
C1orf12 | EGLN1 | EGLN1_HUMAN | Hypoxia-inducible factor prolyl hydroxylase 2 (HIFPH2)
Type:
n/a
Mol. Mass.:
27759.84
Organism:
Homo sapiens (Human)
Description:
EGLN-1-179/426
Residue:
248
Sequence:
LRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF
  
Inhibitor
Name:
BDBM102336
Synonyms:
US10562854, No. C17 | US8536181, C17 | US9278930, C17
Type:
Small organic molecule
Emp. Form.:
C20H26N2O2
Mol. Mass.:
326.4326
SMILES:
CC1CCC(CC1)NCc1ccn(Cc2ccccc2)c(=O)c1O |(8.08,,;6.54,,;5.78,-1.33,;4.23,-1.33,;3.47,,;4.23,1.33,;5.78,1.33,;1.93,,;1.15,1.33,;-.38,1.33,;-1.15,2.67,;-2.69,2.67,;-3.47,1.33,;-5,1.33,;-5.78,,;-7.31,,;-8.08,-1.33,;-7.31,-2.67,;-5.78,-2.67,;-5,-1.33,;-2.69,,;-3.47,-1.33,;-1.15,,;-.38,-1.33,)|
Structure:
Search PDB for entries with ligand similarity: